Your browser doesn't support javascript.
loading
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally, Benjamin; Emberson, Jonathan R; Spata, Enti; Reith, Christina; Davies, Kelly; Halls, Heather; Holland, Lisa; Wilson, Kate; Bhala, Neeraj; Hawkey, Christopher; Hochberg, Marc; Hunt, Richard; Laine, Loren; Lanas, Angel; Patrono, Carlo; Baigent, Colin.
Afiliación
  • Scally B; Emergency Department, Glasgow Royal Infirmary, Glasgow, UK; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, UK.
  • Emberson JR; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, Oxford, UK.
  • Spata E; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, Oxford, UK.
  • Reith C; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, UK.
  • Davies K; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, UK.
  • Halls H; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, UK.
  • Holland L; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, UK.
  • Wilson K; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Oxford, UK.
  • Bhala N; Gastroenterology and Liver Unit, Queen Elizabeth Hospital, Mindelsohn Way, Birmingham, UK; Institute of Applied Health Research, University of Birmingham, Edgbaston, UK.
  • Hawkey C; Nottingham Digestive Diseases Centre, Queen's Medical Centre, Nottingham, UK.
  • Hochberg M; Department of Medicine and Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Hunt R; Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, McMaster University Health Science Centre, Hamilton, ON, Canada.
  • Laine L; Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, USA; VA Connecticut Healthcare System, West Haven, CT, USA.
  • Lanas A; Service of Digestive Diseases, University Clinic Hospital, University of Zaragoza, IIS Aragón, CIBERehd, Zaragoza, Spain.
  • Patrono C; Department of Pharmacology, Catholic University School of Medicine, Rome, Italy.
  • Baigent C; Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, Oxford, UK. Electronic address: colin.baigent@ndph.ox.ac.uk.
Lancet Gastroenterol Hepatol ; 3(4): 231-241, 2018 04.
Article en En | MEDLINE | ID: mdl-29475806

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Úlcera Péptica / Prostaglandinas Sintéticas / Úlcera Péptica Hemorrágica / Inhibidores de la Bomba de Protones / Antagonistas de los Receptores H2 de la Histamina / Antiulcerosos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Úlcera Péptica / Prostaglandinas Sintéticas / Úlcera Péptica Hemorrágica / Inhibidores de la Bomba de Protones / Antagonistas de los Receptores H2 de la Histamina / Antiulcerosos Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Países Bajos